Press Release: Vitamin E Tocotrienol shows increased cancer cell apoptosis without toxicity in phase 1 pancreatic cancer trial
Davos Life Science (DavosLife) has today announced preliminary results of a phase I clinical trial of its Natural e3 delta-tocotrienol (Natural e3) in patients with resectable pancreatic cancer.